ARCHIVES

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Dole Visits Roswell Park, Hails PSA Test

January 28, 1994

NCI Advisors Approve New $5 Million Program For Reagent Contracts.

July 10, 2009

In Brief: Grants Compromise Still In Doubt As Natcher, Conte Hold Out for 6,500; House Marks Up Bill

July 12, 1985

Study: Drug Discounts Used For Wealthier Patients In Many 340B-Enrolled Hospitals

October 10, 2014

Cooperative Group Chairman Blast Cut In’81 Budget

February 15, 1980

NCAB Sets Bypass Budget Figures at $1.074 Billion

May 28, 1982